| Text of Recommendation | CMS should strengthen validation rules and revise data element definitions so that actual drug and device names must be reported |
|---|---|
| Recommendation Number | 5651 |
| Recommendation Status | Closed |
| Significant Recommendation | No |
| Recommendation Questioned Costs | $0 |
| Recommendation Funds for Better Use | $0 |
| Submitting OIG | |
|---|---|
| Linked Report |